Icelandic
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Japanese Journal of Nephrology 2004-Jan

[A case of pseudohypercreatininemia in a patient suffering from macroglobulinemia].

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Krækjan er vistuð á klemmuspjaldið
Mario Yamaki

Lykilorð

Útdráttur

A 56-year-old man with chronic hepatitis was admitted to the nephrology unit because of a progressive increase in serum creatinine(Cr). Blood Urea Nitrogen(BUN) and Cr, measured by the enzymatic method, were 15 and 2.0 mg/dl, respectively, in 1999, and changed to 17 and 3.8 mg/dl, respectively, on February 2000. However, urinalysis did not show any abnormalities. Hypergammaglobulinemia and hypocomplimentemia were observed, but the immune complex level was normal. Major self-antibodies were all negative. MRI renal angiography and renoscintigram, respectively, showed little abnormality. Renal biopsy performed in April revealed no abnormalities. Treatment was started with the administration of steroid, anticoagulation agents and activated charcoal under the hypothesis of serious glomerulonephritis. Cr and Cr clearance (Ccr) aggravated to 5.4 mg/dl and 11.9 ml/min in April, and then returned to 2.7 mg/dl and 22.8 ml/min in May, however, steroid and anticoagulation administration were terminated because the biopsy findings were identified as normal. When cryoglobulinemia was found in August, serum Cr was found to be 1.0 mg/dl when measured by a modified Jaffe's method. Clearance test of p-aminohippurate sodium and sodium thiosulfate, i.e., CPAH and CTHIO, showed normal renal function. After the detection of macroglobulinemia(IGM-lambda), the patient has been treated with the administration of melphalan and prednisolone in the hematology unit since July 2001. Analysis of plasma amino acid showed a high glutaminic acid (Glu) level before the subsequent chemotherapy and dissolution. His serum Cr was 0.9 mg/dl even when measured by the enzymatic method after chemotherapy. A previous report referred to the possibility that enzymatic measurement is affected by the high proline level because of its structural resemblance to Cr, however, the high Glu level in this case did not seem to have this effect because of less resemblance to Cr. Therefore, paraproteinemia is thought to affect enzymatic Cr measurement, and CPAH and CTHIO should be used when as abnormally high Cr level appears.

Skráðu þig á
facebook síðu okkar

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

  • Virkar á 55 tungumálum
  • Jurtalækningar studdir af vísindum
  • Jurtaviðurkenning eftir ímynd
  • Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
  • Lestu vísindarit sem tengjast leit þinni
  • Leitaðu að lækningajurtum eftir áhrifum þeirra
  • Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum

Google Play badgeApp Store badge